Evaluation of nalbuphine for abuse potential.
D000698:Analgesia; D002986:Clinical Trials as Topic; D003516:Cycloparaffins / Q000008:administration & dosage; D006801:Humans; D007700:Kinetics; D009019:Morphinans / Q000008:administration & dosage*; D009020:Morphine / Q000037:antagonists & inhibitors; D009269:Nalorphine / Q000494:pharmacology; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy; D019966:Substance-Related Disorders
D003516:Cycloparaffins; D009019:Morphinans; D009020:Morphine; D009269:Nalorphine